Stichting Hematon

What Stichting Hematon does

Stichting Hematon is a Dutch non-profit patient organization (Stichting under Dutch law) headquartered at Mercatorlaan 1200 in Utrecht, Netherlands, focused exclusively on people affected by blood, bone marrow, and lymph node cancers. Founded in 2011 and operating with 37 employees, the organization serves patients diagnosed with leukemia (ALL, AML, CLL, CML, CMML, HCL, T-PLL), lymphoma (Hodgkin, Non-Hodgkin, Burkitt, Follicular, Mantle cell, T-cell, NK-cell), myeloma (Ziekte van Kahler), MDS-MPN disorders, and stem cell transplant recipients, along with their relatives and the healthcare professionals who treat them. Its core "products" are the hematon.nl information portal, disease-specific content across more than 20 conditions, webinars, themed magazines and booklets, and the lotgenotencontact peer-support service delivered through private Facebook groups, weblogs, and in-person meetings across the Netherlands.

Underlying the service is a website-based content and community platform with basic analytics tooling — there is no proprietary technology stack, no mobile application, and no public API. The organization also operates the Onderzoeksfonds Hematon research fund, the Hematon-Lokhorst Award for hematology research, and the HOPP (Hematon Onderzoek Patiënten Participatie) program for patient participation in research, alongside a separate donation platform at doneren.hematon.nl.

Hematon's revenue model is entirely non-commercial, consisting of individual annual membership fees, voluntary donations from members and supporters, and ANBI-status tax-deductible giving (RSIN 852156364). Go-to-market is community-led: the organization is a member of NFK (Nederlandse Federatie van Kankerpatiëntenorganisaties), with membership enrollment forms hosted through the NFK platform and healthcare-professional materials distributed via webwinkel.kanker.nl. Distribution runs through the website, monthly email newsletters, YouTube, LinkedIn, Facebook, Instagram, webinars, and in-person events, with a geographic footprint restricted to the Netherlands.

Name

Stichting Hematon

Legal name

Stichting Hematon

Website

https://hematon.nl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership fees: Annual membership fees paid by patients and relatives for access to information, peer support, and organizational benefits.
2. Donations: Voluntary donations from members, supporters, and the public to support the organization's mission of patient support and research.
3. ANBI/Charitable status: Stichting Hematon holds ANBI (Algemeen Nut Beogende Instelling) status, enabling tax-deductible donations and supporting charitable funding.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Stichting Hematon is a Dutch non-profit patient organization that provides disease-specific information, peer support, educational webinars, publications, and advocacy for people diagnosed with blood, bone marrow, and lymph node cancers (including leukemia, lymphoma, multiple myeloma, MDS-MPN, and stem cell transplant recipients) and their families. It funds research through the Onderzoeksfonds Hematon and facilitates patient participation in research through its HOPP program.

Product overview

Stichting Hematon operates primarily as a patient organization website and support platform rather than a traditional software product company. The core offering is a comprehensive information portal providing educational content about blood cancers, lymphoma, and related conditions. The portfolio includes a main website with disease-specific information, webinars (both live and recorded), peer support services through lotgenotencontact, printed and digital publications (magazines and themed booklets), and research support programs including the Onderzoeksfonds Hematon and the Hematon-Lokhorst Award. The organization also facilitates patient participation in research through its HOPP program.

Differentiator

Problem solved

Functional benefit

Products and services

• Hematon Information Portal and Membership Online membership and information service offering access to disease-specific content, peer support, and organizational benefits for patients and relatives dealing with blood, bone marrow, or lymph node cancer. Membership is annual and enrolled through the NFK forms platform.
• Webinars Live and recorded online educational sessions on disease-specific topics delivered with expert speakers; accessible to patients, relatives, and the broader public for free.
• Lotgenotencontact (Peer Support) Structured peer support service connecting patients and relatives with others who share similar diagnoses, delivered through Facebook groups, weblogs, personal experience stories, and in-person/online meetings.
• Magazines and Themed Publications Printed and digital publications including Hematon Magazine and themed booklets providing in-depth information about living with and after blood cancer treatment for patients and relatives.
• HOPP Patient Participation Program Program that enables blood cancer patients to participate in and contribute to research projects as research partners, supporting patient involvement in scientific studies.
• Onderzoeksfonds Hematon (Research Fund) Charitable research fund that supports scientific research into blood cancers via donations and grants; supports research grants for the hematology research community in the Netherlands.

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• NFK (Nederlandse Federatie van Kankerpatiëntenorganisaties)coreOthersHematon is part of NFK, the Dutch Federation of Cancer Patient Organizations. Membership enrollment forms are hosted through NFK's platform.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Macmillan Cancer Support: Major UK cancer patient support charity offering information, peer support, financial guidance, and advocacy. Comparable in mission scope (psychosocial + practical patient support), though operating at substantially larger scale and across all cancer types.
• Cancer Research UK: UK's largest cancer charity combining research funding and patient information. Comparable to Hematon's combined patient-information + Onderzoeksfonds research-funding model, though at much larger, all-cancer scale.
• KWF Kankerbestrijding (Dutch Cancer Society): The dominant Dutch cancer charity funding research, providing patient information, and running awareness campaigns. Comparable in mission (patient support + research funding) but operates at much greater scale across all cancer types rather than hematology-specific.
• NFK (Nederlandse Federatie van Kankerpatiëntenorganisaties): Dutch federation of cancer patient organizations and Hematon's parent umbrella. Directly comparable as a Dutch patient-advocacy federation serving multiple cancer types through shared infrastructure, advocacy, and information platforms.
• Leukemia & Lymphoma Society (LLS): U.S. blood cancer patient organization offering peer support, education, advocacy, and research funding — closely parallel to Hematon's hematology-specific scope, but operating at national scale in the United States.

Direct peers

• DKMS: International blood stem cell donor registry and patient advocacy organization. Closely comparable to Hematon's stem cell transplant program work, with overlapping mission on donor recruitment and SCT patient support.
• Anthony Nolan: UK stem cell donor charity supporting SCT patients and donors. Comparable to Hematon in serving stem cell transplant recipients and families, including patient information, peer support, and advocacy.

Emerging players

• Myeloma Patients Europe (MPE): European umbrella for myeloma patient organizations. Comparable as a disease-specific (myeloma/Kahler is one of Hematon's focus areas) patient-advocacy organization with multi-country footprint.
• Lymphoma Coalition: Global network of lymphoma patient organizations. Comparable as a patient-advocacy body for hematological malignancies, with international reach that contrasts with Hematon's Netherlands-only scope.
• CLL Advocates Network: International CLL-specific patient advocacy network. Comparable in disease-specific focus (one of the hematological conditions Hematon covers) and community-led support model, though operating cross-nationally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCey34nrF9MphbcQfyf6V5NQ
• Facebookfacebook.com/hematon.nl
• LinkedInlinkedin.com/company/stichtinghematon
• Instagraminstagram.com/_hematon_

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stichting Hematon